Matches in Nanopublications for { ?s ?p "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP608037.RADEyHFxwQQUlvoVgcdWjbenJQRlpcXASl5GVaxs0Cg-0130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608037.RADEyHFxwQQUlvoVgcdWjbenJQRlpcXASl5GVaxs0Cg-0130_provenance.
- NP924390.RAbm__tevkhP1j3M5bDz19M_bmsYIkq4HbV0L7NbIxC3U130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924390.RAbm__tevkhP1j3M5bDz19M_bmsYIkq4HbV0L7NbIxC3U130_provenance.
- assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP270229.RAqRMjulaNMJa3rRhgq0Ebl8b7qNYWcEQz6LF2DDeZmLE130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270229.RAqRMjulaNMJa3rRhgq0Ebl8b7qNYWcEQz6LF2DDeZmLE130_provenance.
- NP270239.RAtzQytyj--CMMFwj0d-e3Cck4ZWJQKzsrGxTKildAcug130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270239.RAtzQytyj--CMMFwj0d-e3Cck4ZWJQKzsrGxTKildAcug130_provenance.
- NP1311794.RABM3qwygpD8acEpxztZ8EI0F6gieeJphHZLvqm2kOZuU130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311794.RABM3qwygpD8acEpxztZ8EI0F6gieeJphHZLvqm2kOZuU130_provenance.
- NP1311795.RAiErLA-3nNENtAciJCdWbC2gbt3BBn3g9JJZxUCpcUL0130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311795.RAiErLA-3nNENtAciJCdWbC2gbt3BBn3g9JJZxUCpcUL0130_provenance.
- NP1311796.RA-LG5JJ5wnFu6TPAY_n2MhOE3nYlAAZdW0VI8R4WPjGw130_assertion description "[To develop a new method to evaluate autoantibodies in various autoimmune bullous skin diseases, we examined reactivity of bullous pemphigoid (BP) and pemphigus vulgaris (PV) patients' sera with partial bacterial fusion proteins of the 230 kD BP antigen (BPAG1) and PV antigen, respectively, by an enzyme-linked immunosorbent assay (ELISA), and compared the results with those of immunoblotting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311796.RA-LG5JJ5wnFu6TPAY_n2MhOE3nYlAAZdW0VI8R4WPjGw130_provenance.